Source: Frontiers in Immunology. Unidades: FCFRP, FMRP
Subjects: AUTOIMUNIDADE, CÉLULAS VEGETAIS, TRANSPLANTE DE ÓRGÃOS, BIOMARCADORES, DIABETES MELLITUS, TRANSPLANTE AUTÓLOGO, IMUNOSSUPRESSÃO
ABNT
COURI, Carlos E. B. e FARIAS, Kelen Cristina Ribeiro Malmegrim de e OLIVEIRA, Maria Carolina. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Frontiers in Immunology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.01086. Acesso em: 21 out. 2024.APA
Couri, C. E. B., Farias, K. C. R. M. de, & Oliveira, M. C. (2018). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Frontiers in Immunology, 9. doi:10.3389/fimmu.2018.01086NLM
Couri CEB, Farias KCRM de, Oliveira MC. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 out. 21 ] Available from: https://doi.org/10.3389/fimmu.2018.01086Vancouver
Couri CEB, Farias KCRM de, Oliveira MC. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 out. 21 ] Available from: https://doi.org/10.3389/fimmu.2018.01086